Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
Status:
Withdrawn
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study is to find out about whether two sessions of psilocybin-assisted psychotherapy are
safe and will help people who are anxious as a result of having stage IV melanoma and will
involve two sessions of psychotherapy combined with either 4 or 25 mg psilocybin. The study
will measure anxiety, depression, quality of life and spirituality before and after
psilocybin-assisted psychotherapy, natural killer cells (a type of immune cell) will be
counted from blood samples taken the day after psilocybin-assisted psychotherapy, and people
will keep daily diaries reporting on how anxious they feel for each day in the study.
Phase:
Phase 2
Details
Lead Sponsor:
Multidisciplinary Association for Psychedelic Studies